Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-07

Clinical Trial Update: Fibrinogen Concentrate vs Cryoprecipitate [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fibrinogen concentrate with cryoprecipitate in congenital heart disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cryoprecipitate (cryoprecipitate)
  • Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: Stanford University | Conditions: Congenital Heart Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-05-07